Stock & Company Details
GH Research PLC $GHRS
Price:
N/A
N/A
69M
$1.4B
52 Week High:
N/A
10 Day Average Volume:
N/A
-22.48
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Services
GHRS technical indicators
Latest GH Research PLC (GHRS) indicator readings as of 2026-10-09.
GHRS's 14-day RSI is 29.0, in oversold territory. At $21.11 it is trading 0.3% below its 200-day moving average of $21.18, and below its 50-day average of $27.07. Price sits near the lower Bollinger Band ($19.23 to $30.16). ADX reads 31.8, indicating a trending market.
Overview
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. Its focus is on developing novel and proprietary 5-Methoxy-N,N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.
Finance Bot
Ask your questions
Start by typing a question below.
